Principal Financial Group Inc Neuronetics, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.09 - $3.71 $50,463 - $89,577	-24,145 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$2.84 - $4.52 $31,274 - $49,774	-11,012 Reduced 31.32%	24,145 $73,000
Q4 2021 Feb 09, 2022	SELL	$3.87 - $6.59 $25,255 - $43,006	-6,526 Reduced 15.66%	35,157 $157,000
Q3 2021 Nov 09, 2021	SELL	$6.22 - $15.54 $6,748 - $16,860	-1,085 Reduced 2.54%	41,683 $273,000
Q2 2021 Aug 10, 2021	BUY	$10.15 - $17.25 $434,095 - $737,748	42,768 New	42,768 $685,000
Q3 2018 Nov 14, 2018	SELL	$24.32 - $37.54 $559,165 - $863,119	-22,992 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$26.61 - $27.78 $611,817 - $638,717	22,992 New	22,992 $0

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.